当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析 - 现金流量表

中国医药

(600056)

  

流通市值:163.14亿  总市值:163.20亿
流通股本:14.95亿   总股本:14.96亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金25,296,007,858.1216,726,433,633.227,251,831,214.3635,320,534,540.55
  收到的税费返还102,830,821.2967,253,052.1637,038,898.21127,069,084.37
  收到其他与经营活动有关的现金878,121,718.02551,064,558.97149,730,342.85796,381,084.76
  经营活动现金流入小计26,276,960,397.4317,344,751,244.357,438,600,455.4236,243,984,709.68
  购买商品、接受劳务支付的现金23,365,781,925.5315,624,326,535.957,782,333,031.8831,283,451,498.6
  支付给职工以及为职工支付的现金1,139,571,802.91806,685,508.31427,410,160.711,517,162,123.98
  支付的各项税费797,251,952.33560,338,694.36256,686,197.4936,908,642.46
  支付其他与经营活动有关的现金1,286,892,517.67899,533,477.26453,747,307.851,501,031,895.02
  经营活动现金流出小计26,589,498,198.4417,890,884,215.888,920,176,697.8435,238,554,160.06
  经营活动产生的现金流量净额-312,537,801.01-546,132,971.53-1,481,576,242.421,005,430,549.62
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额18,078,258.7617,687,076.198,187,430.1943,839,414.21
  收到的其他与投资活动有关的现金9,862,663.639,862,663.63-3,600
  投资活动现金流入小计27,940,922.3927,549,739.828,187,430.1943,843,014.21
  购建固定资产、无形资产和其他长期资产支付的现金209,638,249.8124,980,900.6861,362,248.21358,624,567.29
  投资支付的现金---41,020,000
  取得子公司及其他营业单位支付的现金4,134,7394,134,7394,134,73911,855,061
  投资活动现金流出小计213,772,988.8129,115,639.6865,496,987.21411,499,628.29
  投资活动产生的现金流量净额-185,832,066.41-101,565,899.86-57,309,557.02-367,656,614.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金20,000,0004,000,000400,0009,000,000
  其中:子公司吸收少数股东投资收到的现金20,000,0004,000,000400,0009,000,000
  取得借款收到的现金3,401,822,921.352,290,423,133.371,469,845,625.66,410,721,930.07
  收到其他与筹资活动有关的现金5,681,057.975,681,057.975,681,057.9772,281,229.75
  筹资活动现金流入小计3,427,503,979.322,300,104,191.341,475,926,683.576,492,003,159.82
  偿还债务支付的现金3,326,919,569.322,105,060,985.381,264,424,3085,470,430,847.29
  分配股利、利润或偿付利息支付的现金445,346,955.58196,667,100.0133,284,431.87589,214,420.16
  其中:子公司支付给少数股东的股利、利润162,165,661.76156,062,077.2-78,304,855.48
  支付其他与筹资活动有关的现金771,047,278.82723,346,681.24131,518,487.8690,591,802.18
  筹资活动现金流出小计4,543,313,803.723,025,074,766.631,429,227,227.676,750,237,069.63
  筹资活动产生的现金流量净额-1,115,809,824.4-724,970,575.2946,699,455.9-258,233,909.81
四、汇率变动对现金及现金等价物的影响-4,976,557.26-1,024,669.09-842,648.331,779,865.31
五、现金及现金等价物净增加额-1,619,156,249.08-1,373,694,115.77-1,493,028,991.87381,319,891.04
  加:期初现金及现金等价物余额3,857,149,690.473,857,149,690.473,711,578,829.813,330,258,938.77
  期末现金及现金等价物余额2,237,993,441.392,483,455,574.72,218,549,837.943,711,578,829.81
补充资料:
  净利润-375,327,120.46-686,623,882.02
  资产减值准备--265,715.11-175,325,505.38
  固定资产和投资性房地产折旧-120,224,474.85-244,449,774.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧---244,449,774.72
  无形资产摊销-46,699,541.15-80,475,955.69
  长期待摊费用摊销-29,558,630.05-64,623,194.97
  处置固定资产、无形资产和其他长期资产的损失--7,371,175.2--1,653,400.91
  固定资产报废损失-577,796.02--1,944,335.44
  公允价值变动损失--5,891,042.55--127,466,901.01
  财务费用--1,784,884.19-206,833,463.14
  投资损失--28,354,956.85--18,690,363.11
  递延所得税--14,057,919.65-2,641,680.61
  其中:递延所得税资产减少--14,089,320.51--29,910,011.24
    递延所得税负债增加-31,400.86-32,551,691.85
  存货的减少-36,494,403.08-452,705,276.79
  经营性应收项目的减少--1,933,735,919.06-1,882,963,521.95
  经营性应付项目的增加-614,650,987.78--2,964,554,965.04
  不涉及现金收支的投资和筹资活动金额其他项目---89,281,494.46
  现金的期末余额-2,483,455,574.7-3,711,578,829.81
  减:现金的期初余额-3,853,292,207.58-3,330,258,938.77
  减:现金等价物的期初余额-3,857,482.89--
  现金及现金等价物的净增加额--1,373,694,115.77-381,319,891.04
公告日期2025-10-282025-08-282025-04-302025-04-26
审计意见(境内)标准无保留意见
TOP↑